Associate Director, Oncology Lifecycle Management - Hematologic Oncology

Position Summary

Natera a Global Leader in cell-free DNA testing focused on changing the management of disease in reproductive health, oncology, and organ transplantation. Signatera is a personalized, tumor-informed test for molecular residual disease (MRD) assessment and surveillance monitoring in patients previously diagnosed with cancer. Signatera is covered by Medicare for colorectal cancer, muscle invasive bladder cancer, high-risk breast cancer, ovarian cancer, lung cancer, and immunotherapy response monitoring for any solid tumor.

As an Associate Director of Oncology Lifecycle Management for Hematologic Malignancies you will work in a highly matrixed environment to help shape the strategic direction and drive execution for company success in Hematologic Oncology.

Primary Responsibilities

• Own the lifecycle planning and successful product launch for a diagnostic portfolio in Hematologic Malignancies, including Lymphoma, Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL), collaborating with cross-functional teams to develop and execute a strategic plan that drives usage, awareness, and advocacy across key stakeholders worldwide.
• Lead a MM/CLL Lifecycle Team that is a cross-functional team accountable for progress on tumor goals and deploying resources to maximize outcomes.
• Establish tumor-specific goals to be owned by the lifecycle team and across functions.
• Serve as a critical member of clinical/medical teams, helping define and prioritize key indications while identifying and addressing evidence gaps.
• Serve as a critical member on commercial subteams, helping to maximize Natera potential by escalating and addressing critical barriers that limit commercial adoption.
• Maintain a deep expertise in the Hematology Oncology space by integrating real-time customer insights, publications, data presentations, competitive and market intelligence.
• Drive market access efforts, leading the development of reimbursement dossiers for Medicare/MolDx and commercial payers to secure coverage for non-covered indications.
• Develop and execute KOL engagement strategies, collaborating with marketing and medical teams to gather insights, build relationships, and foster advocacy.
• Shape the value proposition for Natera’s oncology products in collaboration with Medical Affairs and Commercial Marketing, leveraging clinical evidence and market dynamics.
• Co-lead advisory boards and market research efforts in partnership with Medical Affairs.
• Regularly present strategic plans and progress to executive leadership.

Qualifications

• Bachelor’s degree with 5+ years of relevant experience; advanced degree preferred (MBA or PhD)
• Hematologic oncology experience strongly preferred
• 5+ years experience in product marketing, market analytics at a pharmaceutical / biotech company
• Previous KOL management experience preferred
• Working knowledge of oncology molecular testing / biomarkers
• ~25% travel required (advisory boards, congresses, sales / marketing meetings, customer meetings)

Knowledge, Skills, Abilities

• Ability to lead without authority, influence and inspire individuals
• Proven strategic agility with an enterprise mindset and ability to operate with executive presence
• Ability to partner and collaborate across a broad range of internal and external partners
• Strong customer orientation and focus, particularly establishing thought leader relationships
• Proven ability to communicate the complex simply (biomarkers, multiple indications, etc.)